As previously reported, Oppenheimer analyst Christopher Glynn upgraded Nordson to Outperform from Perform, with a $140 price target. The analyst notes that the company has delivered organic growth for nine straight years through FY18, and guided FY19 for 3%-5% organic growth and 100bps-150 bps OM expansion. Organic growth was slightly negative over the prior three quarters and will certainly be so in FY1Q18 on a particularly onerous comparison, but that is all well known, he contends. While Glynn acknowledges that shares are not cheap in the current market, he expects about 110% structural free cash flow/NI long-term and 120% in FY19 on expected solid working capital execution versus historical, including some benefits from facilities consolidations at ADS.